OneMedNet (NASDAQ:ONMD) Stock: Insider Robert Lawrence Golden Sells 2,500 Shares

OneMedNet Corporation (NASDAQ:ONMD) CFO Robert Golden sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $6.60, for a total value of $16,500.00. Following the completion of the sale, the chief financial officer directly owned 97,291 shares of the company’s stock, valued at $642,120.60. This trade represents a 2.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Lawrence Golden also recently made the following trade(s):

• On Monday, September 21st, Robert Golden sold 3,000 shares of OneMedNet stock. The shares were sold at an average price of $6.63, for a total value of $19,890.00.
• On Tuesday, September 15th, Robert Golden sold 3,000 shares of OneMedNet stock. The stock was sold at an average price of $6.30, for a total value of $18,900.00.

OneMedNet Trading Up 17.2%

Shares of ONMD opened at $4.71 on Thursday. OneMedNet Corporation has a 12-month low of $3.61 and a 12-month high of $31.00. The business’s fifty day moving average is $6.07 and its 200 day moving average is $7.22.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.